Table: Fuji Pharmaceutical -2022/23 group results

Fuji Pharma

09/11/2023 08:00

Nov 9 (Reuters)- 
          Fuji Pharmaceutical  Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Sep 30, 2023    Sep 30, 2022   Sep 30, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           40.89           35.43          48.93        23.67    
               (+15.4 pct)     (+4.2 pct)     (+19.7 pct)  (+23.1 pct) 
  Operating        3.86            3.78           4.91         2.05    
               (+2.1 pct)      (+12.8 pct)    (+27.2 pct)  (+12.4 pct) 
  Recurring        4.52            3.73           5.56         2.79    
               (+21.3 pct)     (+14.6 pct)    (+23.1 pct)  (+13.7 pct) 
  Net
  Net              3.44            2.70           4.02         1.97    
               (+27.4 pct)     (+10.9 pct)    (+16.9 pct)  (+10.9 pct) 
  EPS          141.37 yen      111.01 yen     165.22 yen    80.86 yen  
  Ann Div       37.00 yen       35.00 yen      42.50 yen               
  -Q2 Div       17.00 yen       15.00 yen      20.00 yen               
  -Q4 Div       20.00 yen       20.00 yen      22.50 yen               
  
  NOTE - Fuji Pharmaceutical  Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T